VERU INC. Extinguishment of Debt, Amount
VERU INC. (VERU) reported Extinguishment of Debt, Amount of $8.14 million for the 12-month period ending 2025-09-30, per its 10-K filed 2025-12-17.
Financial Statements › Notes
us-gaap:ExtinguishmentOfDebtAmount · last filed 2025-12-17
- VERU INC. extinguishment of debt, amount for the quarter ending 2025-09-30 was $0.00.
- VERU INC. extinguishment of debt, amount for the quarter ending 2025-06-30 was $0.00.
- VERU INC. extinguishment of debt, amount for the quarter ending 2025-03-31 was $0.00.
- VERU INC. extinguishment of debt, amount for the quarter ending 2024-12-31 was $8.14M.
- VERU INC. extinguishment of debt, amount for fiscal 2025 was $8.14M.
- VERU INC. extinguishment of debt, amount for fiscal 2024 was $0.00.
| Period end | Extinguishment of Debt, Amount 3 month | Extinguishment of Debt, Amount 6 month | Extinguishment of Debt, Amount 9 month | Extinguishment of Debt, Amount 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $0.00 derived: sum of 2 quarters · filed 2025-12-17 | $0.00 derived: sum of 3 quarters · filed 2025-12-17 | $8.14M 10-K · filed 2025-12-17 |
| 2025-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-12 | $0.00 derived: sum of 2 quarters · filed 2025-08-12 | $8.14M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-08 | $8.14M 10-Q · filed 2025-05-08 | ||
| 2024-12-31 | $8.14M 10-Q · filed 2025-02-13 | |||
| 2024-09-30 | $0.00 10-K · filed 2025-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |